Atacor announced first patient enrollment in ALARION-EV study

AtaCor Medical, Inc., a privately-held medical device company, announced the enrollment of the first patient in the ALARION-EV study to evaluate its Atala&#x2122; parasternal extravascular lead with an Abbott implantable cardioverter-defibrillator (EV-ICD). The Atala&#x2122; lead is implanted through a small left parasternal incision, with the lead positioned through a rib space and electrodes…